Hawkins’ (HWKN) Buy Rating Reiterated at BWS Financial

by · The Markets Daily

Hawkins (NASDAQ:HWKN – Get Free Report)‘s stock had its “buy” rating reaffirmed by BWS Financial in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $200.00 target price on the specialty chemicals company’s stock. BWS Financial‘s target price points to a potential upside of 30.00% from the company’s previous close.

Several other research analysts have also commented on HWKN. Barclays set a $141.00 price objective on shares of Hawkins and gave the stock an “equal weight” rating in a research note on Tuesday, October 13th. Weiss Ratings raised shares of Hawkins from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, September 21st. Finally, Zacks Research lowered shares of Hawkins from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 4th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Hawkins has an average rating of “Hold” and an average target price of $170.50.

Read Our Latest Report on HWKN

Hawkins Price Performance

Shares of HWKN stock traded up $18.41 on Tuesday, reaching $153.85. The company’s stock had a trading volume of 423,990 shares, compared to its average volume of 164,276. The stock’s fifty day simple moving average is $126.44 and its 200-day simple moving average is $143.14. Hawkins has a 1 year low of $116.04 and a 1 year high of $174.12. The company has a current ratio of 2.27, a quick ratio of 1.54 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $3.21 billion, a price-to-earnings ratio of 39.86, a price-to-earnings-growth ratio of 2.71 and a beta of 0.74.

Hawkins (NASDAQ:HWKN – Get Free Report) last posted its earnings results on Monday, October 26th. The specialty chemicals company reported $1.34 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.15. Hawkins had a net margin of 7.29% and a return on equity of 15.42%. The firm had revenue of $313.82 million during the quarter, compared to analyst estimates of $302.70 million. Analysts forecast that Hawkins will post 4.07 earnings per share for the current fiscal year.

Insider Buying and Selling at Hawkins

In other Hawkins news, CFO Jeffrey Oldenkamp bought 1,290 shares of the firm’s stock in a transaction dated Thursday, August 27th. The stock was acquired at an average cost of $119.00 per share, for a total transaction of $153,510.00. Following the completion of the transaction, the chief financial officer owned 104,223 shares in the company, valued at $12,402,537. This trade represents a 1.25% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Douglas Lange bought 910 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The shares were acquired at an average price of $118.75 per share, with a total value of $108,062.50. Following the completion of the transaction, the vice president owned 28,169 shares of the company’s stock, valued at approximately $3,345,068.75. The trade was a 3.34% increase in their position. The disclosure for this purchase is available in the SEC filing. 3.70% of the stock is currently owned by company insiders.

Institutional Trading of Hawkins

Several institutional investors and hedge funds have recently made changes to their positions in the business. Gibbs Wealth Management lifted its position in shares of Hawkins by 4.8% during the third quarter. Gibbs Wealth Management now owns 3,158 shares of the specialty chemicals company’s stock worth $398,000 after purchasing an additional 146 shares during the last quarter. Sterling Capital Management LLC lifted its stake in Hawkins by 842.0% in the third quarter. Sterling Capital Management LLC now owns 650 shares of the specialty chemicals company’s stock worth $82,000 after acquiring an additional 581 shares during the period. Inspire Investing LLC lifted its stake in Hawkins by 4.0% in the third quarter. Inspire Investing LLC now owns 5,032 shares of the specialty chemicals company’s stock worth $634,000 after acquiring an additional 194 shares during the period. Curry Webb Wealth Management LLC purchased a new stake in Hawkins in the third quarter worth about $77,000. Finally, Diversify Advisory Services LLC lifted its stake in Hawkins by 4.9% in the third quarter. Diversify Advisory Services LLC now owns 13,549 shares of the specialty chemicals company’s stock worth $1,786,000 after acquiring an additional 634 shares during the period. 69.71% of the stock is currently owned by institutional investors.

Trending Headlines about Hawkins

Here are the key news stories impacting Hawkins this week:

  • Positive Sentiment: Earnings and revenue exceeded expectations. Hawkins reported adjusted EPS of $1.34, up from $1.08 a year earlier and above analyst estimates of approximately $1.19–$1.22. Revenue increased 11.9% year over year to $313.8 million, surpassing estimates near $302.7 million. Hawkins fiscal second-quarter results
  • Positive Sentiment: Profitability and cash generation improved. Gross profit rose to $76.6 million, operating profit reached $41.9 million, and net income attributable to common shareholders increased to $27.8 million. Operating cash flow was $40.3 million, supporting the market’s positive reaction to the report.
  • Positive Sentiment: BWS Financial reaffirmed its “buy” rating and raised or maintained a $200 price target, implying substantial upside from the recent trading level. This reinforces bullish sentiment following the earnings beat. BWS Financial rating
  • Positive Sentiment: The quarterly dividend was increased. Hawkins declared a $0.20-per-share dividend payable November 25, representing a 5.3% increase from the prior $0.19 payment and a $0.80 annualized payout. Hawkins dividend announcement
  • Neutral Sentiment: Recent filings and market data indicate some insider purchases and mixed institutional positioning. These signals may support confidence but are less significant than the earnings results and analyst target.

About Hawkins

(Get Free Report)

Hawkins, Inc (NASDAQ:HWKN) is a chemical manufacturer, blender and distributor serving customers across the United States. The company supplies a range of water treatment chemicals, industrial chemicals and specialty products to municipal, commercial and industrial users.

Its water treatment business provides chemicals and related solutions used in drinking water, wastewater and industrial water treatment applications. Hawkins also serves the industrial, health and nutrition, and specialty chemical markets, offering products such as chemical blends, custom formulations and other materials used in manufacturing, agriculture, food processing and pharmaceutical applications.

Founded in 1938, Hawkins is headquartered in Roseville, Minnesota, and operates through a network of manufacturing, blending, distribution and sales locations in the United States.

Further Reading